XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 91 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $421,000 | -8.5% | 93,400 | 0.0% | 0.00% | – |
| Q4 2020 | $460,000 | -18.7% | 93,400 | -2.1% | 0.00% | -100.0% |
| Q3 2020 | $566,000 | +181.6% | 95,400 | +26.4% | 0.00% | – |
| Q2 2020 | $201,000 | +142.2% | 75,500 | +76.8% | 0.00% | – |
| Q1 2020 | $83,000 | -72.4% | 42,700 | 0.0% | 0.00% | – |
| Q4 2019 | $301,000 | – | 42,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|